Counterpoint Mutual Funds’s GoodRx Holdings GDRX Stock Holding History

Counterpoint Mutual Funds’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,364	Closed	-$294K	–	370
2025 Q4	$294K	Buy	+108,364	New	+$356K	0.02%	275
2025 Q3	–	Sell	-76,743	Closed	-$382K	–	389
2025 Q2	$382K	Buy	76,743 +971	+1%	+$4.22K	0.03%	202
2025 Q1	$334K	Sell	75,772 -80,667	-52%	-$379K	0.05%	256
2024 Q4	$727K	Buy	+156,439	New	+$860K	0.09%	81
2024 Q3	–	Sell	-58,407	Closed	-$456K	–	321
2024 Q2	$456K	Buy	58,407 +23,720	+68%	+$176K	0.11%	64
2024 Q1	$246K	Buy	34,687 +15,052	+77%	+$99.6K	0.06%	131
2023 Q4	$132K	Sell	19,635 -21,731	-53%	-$122K	0.05%	79
2023 Q3	$233K	Buy	+41,366	New	+$276K	0.19%	36
2023 Q2	–	Sell	-14,484	Closed	-$90.5K	–	377
2023 Q1	$90.5K	Buy	+14,484	New	+$80.7K	0.08%	301

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Counterpoint Mutual Funds's GDRX Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 108,364 shares — an estimated $294K sold.

Counterpoint Mutual Funds first reported a position in GDRX in Q1 2023 and held it in 9 quarters. The position peaked at $727K in Q4 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

Counterpoint Mutual Funds reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
Counterpoint Mutual Funds sold 108,364 GoodRx Holdings shares in Q1 2026, an estimated $294K.
Counterpoint Mutual Funds first reported a position in GoodRx Holdings in Q1 2023 and held it in 9 quarters.
Counterpoint Mutual Funds's GoodRx Holdings position peaked at $727K in Q4 2024.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.